药品合理定价影响因素研究  

Study on the influencing factors of drug rational pricing

作　　者：杨丽娟[1] 张宇晴 张丽芳[1] 甄健存[1] YANG Lijuan;ZHANG Yuqing;ZHANG Lifang;ZHEN Jiancun(Beijing Jishuitan Hospital,No.31,Xinjiekou East Road,Xicheng District,Beijing,100035,PRC)

机构地区：[1]北京积水潭医院 [2]中国医院协会药事管理专业委员会

出　　处：《中国医院》2018年第10期23-25,共3页Chinese Hospitals

摘　　要：目的:探讨药品合理定价的影响因素。方法:问卷调查国内公立医疗机构药学部门负责人,重点从药品采购、药品短缺、医保支付3方面调查了解药学部门负责人对于影响药品合理定价因素的看法。结果:医疗机构希望提高在药品采购中的参与度和主动权;造成药品短缺的原因除了价格过低外,还有采购政策限制、原材料供应不足、协调保障响应机制不完善等;国内公立医疗机构目前医保支付方式以按总额预付、按病种付费、按项目付费、按疾病诊断相关分组付费为主。结论:应建立多方参与的药品定价体系,建立卫生经济评价体系,加强动态监测反馈及调整,强化药品分级分类定价及管理,充分发挥药学人员在药品合理定价中的专业作用。Objectives:To explore the factors affect the drug rational pricing.Methods:Drug rational pricing influences focused on drug procurement,drug shortage and medical insurance payment were investigated through a questionnaire survey of pharmacy department heads in public hospital in China.Results:Medical institutions hoped to increase their participation and initiative in drug procurement.The causes of drug shortages were not only low prices,but also procurement policy restrictions,insufficient supply of raw materials,imperfect of coordination,guarantee and response mechanism,etc.The current medical insurance payments were based on global budget,paid per case,fee for service and DRGs.Conclusions:It is considered to build multi-participated drug pricing mechanism,constructing health economics assessment system,strengthening dynamical monitoring and adjustment,strengthening drug classification and pricing management to full play clinical pharmacist’s role.

关 键 词：药品合理定价 药品采购 药品短缺 医保支付方式 

分 类 号：R195[医药卫生—卫生统计学]